(Q36292760)

13 August 2017

Cyclophosphamide, methotrexate and infusional 5-fluorouracil (infusional CMF) in metastatic breast cancer (English)

1 reference

13 August 2017

metastatic breast cancer

1 reference

1 reference

1 reference

O'Byrne KJ

1

1 reference

13 August 2017

Koukourakis MI

2

1 reference

13 August 2017

Saunders MP

3

1 reference

13 August 2017

Salisbury AJ

4

1 reference

13 August 2017

Isaacs R

5

1 reference

13 August 2017

Varcoe S

6

1 reference

13 August 2017

Taylor M

7

1 reference

13 August 2017

Ganesan TS

8

1 reference

13 August 2017

Harris AL

9

1 reference

13 August 2017

Talbot DC

10

1 reference

13 August 2017

language of work or name

English

0 references

publication date

1 June 1998

1 reference

British Journal of Cancer

13 August 2017

1 reference

13 August 2017

77

1 reference

13 August 2017

11

1 reference

13 August 2017

1950-1956

1 reference

https://scigraph.springernature.com/pub.10.1038/bjc.1998.323

13 August 2017

0 references

cites work

Comparison of adjuvant chemotherapy with methotrexate and fluorouracil with and without cyclophosphamide in breast cancer patients with one to three positive axillary lymph nodes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2150339

Complications of indwelling venous access devices in cancer patients

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2150339

Treatment of metastatic breast cancer: present and future prospects.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2150339

Preclinical and clinical aspects of biomodulation of 5-fluorouracil

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2150339

Dose-response in the treatment of breast cancer: a critical review

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2150339

Low-dose continuous infusion 5-fluorouracil. Evaluation in advanced breast carcinoma

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2150339

Pyridoxine therapy for palmar-plantar erythrodysesthesia associated with continuous 5-fluorouracil infusion

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2150339

5-Fluorouracil by Protracted Venous Infusion: A Review of Recent Clinical Studies

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2150339

Cytotoxic treatment of metastatic breast cancer. Which drugs and drug combinations to use?

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2150339

Fluorouracil therapy in patients with carcinoma of the large bowel: a pharmacokinetic comparison of various rates and routes of administration

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2150339

Reevaluation of the maximum tolerated dose of continuous venous infusion of 5-fluorouracil with pharmacokinetics

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2150339

A comparison of patient-reported side effects among three chemotherapy regimens for breast cancer.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2150339

Clinical pharmacokinetics of 5-fluorouracil and its metabolites in plasma, urine, and bile

29 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2150339

5-Fluorouracil rechallenge by protracted infusion in refractory breast cancer.

29 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2150339

A randomized trial of two dose levels of cyclophosphamide, methotrexate, and fluorouracil chemotherapy for patients with metastatic breast cancer.

29 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2150339

Tunneled catheter thrombosis: factors related to incidence.

29 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2150339

Long-term survival of patients treated with combination chemotherapy for metastatic breast cancer

29 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2150339

Primary medical (neo-adjuvant) chemotherapy for operable breast cancer

29 June 2018

1 reference

12 December 2020

High complete remission rates with primary neoadjuvant infusional chemotherapy for large early breast cancer

1 reference

12 December 2020

The role of taxanes in the treatment of breast cancer

1 reference

12 December 2020

Interim Analysis of a Phase II study of epirubicin and paclitaxel as first-line therapy in patients with metastatic breast cancer

1 reference

12 December 2020

A pilot study of infusional CMF (CMF-inf): active and well tolerated in breast cancer. The Edinburgh Breast Group

1 reference

12 December 2020

Phase I study of protracted venous infusion of 5-fluorouracil

1 reference

12 December 2020

Nonlinear pharmacokinetics for the elimination of 5-fluorouracil after intravenous administration in cancer patients

1 reference

12 December 2020

Protracted ambulatory venous infusion of 5-fluorouracil

1 reference

12 December 2020

Continuous 5-fluorouracil infusion in refractory carcinoma of the breast

1 reference

12 December 2020

Very low doses of warfarin can prevent thrombosis in central venous catheters. A randomized prospective trial

1 reference

12 December 2020

"Classical" CMF versus a 3-weekly intravenous CMF schedule in postmenopausal patients with advanced breast cancer. An EORTC Breast Cancer Co-operative Group Phase III Trial (10808)

1 reference

12 December 2020

MMM (mitomycin/mitoxantrone/methotrexate): an effective new regimen in the treatment of metastatic breast cancer

1 reference

12 December 2020

Phase II study of continuous infusion fluorouracil with epirubicin and cisplatin in patients with metastatic and locally advanced breast cancer: an active new regimen

1 reference

12 December 2020

Identifiers

DOI

10.1038/BJC.1998.323

1 reference

13 August 2017

1 reference

13 August 2017

PubMed publication ID

9667673

1 reference